Skip to main content
Clinical Trials/ITMCTR2000004038
ITMCTR2000004038RecruitingPhase 1

A clinical program of chinese medicine combining the information platform of six six brains to diagnose and treat cognitive impairment in the elderly

Shanghai TCM Hospital.0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Ages
60 to 85 (—)
Sex
All

Inclusion Criteria

  • 1. Subjects, both male and female, aged over 60 (including 60);
  • 2. Ability to participate in neuropsynthetic activities with clear consciousness, hearing and visual ability is normal;
  • 3. Conforms to MCI's diagnostic criteria: at the same time meets the following: 1) the patient or informed person subjectively feels a decline in cognitive function;
  • 4. Does not meet the diagnostic criteria for dementia; Chinese version of the Dementia Assessment Scale (CDR) is divided into 0.0 to 0.5;
  • 5. Montreal scale Chinese version (MoCA) has a total score of less than 26 points (12 years of education, MoCA 25 points);
  • 6. Agree to sign an informed consent and volunteer.

Exclusion Criteria

  • 1. Have a history of mental illness (e.g. separation disorder, obsessive compulsive disorder, personality disorder, schizophrenia, bipolar disorder, severe depression disorder, anxiety disorder, etc.);
  • 2. Persons with a history of drug or alcohol dependence or allergies to the drug in this study.

Investigators

Sponsor
Shanghai TCM Hospital.

Similar Trials